CONVALESCENT plasma for COVID-19: A meta-analysis of clinical trials and real-world evidence.

Convalescent plasma use was associated with reduced risk of all-cause mortality in severe or critical COVID-19 patients. However, the findings were limited with a moderate degree of heterogeneity. Further studies with well-designed and larger sample size are needed.